Viatris Inc.
VTRSLast close · Oct 16, 202618.66+0.43 (+2.39%)
Market cap$21.4B
4 firms' latest targets, last 90 days: median $22.50 ($20.00–$26.00), 21% above the last close.
Price and published targets
Each firm's latest target
| Date | Firm | Target | Change | Vs price now |
|---|---|---|---|---|
| 2026-10-05 | UBS | $26.00 | ▲ 44% | +39% |
| 2026-09-23 | Oppenheimer | $25.00 | — | +34% |
| 2026-09-09 | Leerink Partners | $20.00 | — | +7% |
| 2026-09-08 | Argus Research | $20.00 | ▲ 33% | +7% |
Consensus estimates
| FY | Revenue | YoY | EPS | YoY | Revenue range | EPS range | Analysts |
|---|---|---|---|---|---|---|---|
| 2023reported | $15.4B | -5% | $0.05 | -97% | est. $15.5B-1% | est. $2.96 | 4 |
| 2024reported | $14.7B | -5% | -$0.53 | -1160% | est. $14.8B-1% | est. $2.68 | 5 |
| 2025reported | $14.3B | -3% | -$3.00 | — | est. $14.1B+1% | est. $2.32 | 6 |
| 2026 | $14.8B | +4% | $2.52 | +9% | $14.8B–$14.8B | $2.47–$2.56 | 7 |
| 2027 | $15.0B | +2% | $2.69 | +7% | $14.9B–$15.4B | $2.60–$2.80 | 7 |
| 2028 | $15.5B | +3% | $2.87 | +7% | $15.2B–$15.8B | $1.85–$4.02 | 6 |
| 2029 | $16.1B | +4% | $2.90 | +1% | $15.9B–$16.4B | $2.86–$2.96 | 4 |
| 2030 | $16.9B | +5% | $3.07 | +6% | $16.7B–$17.2B | $3.03–$3.13 | 3 |
Targets, grades and estimates are quoted from third parties (via Financial Modeling Prep) and are theirs, not ours; each target links to the report it was published in. A firm counts once, at its latest target or grade.